Structure Therapeutics Inc.
GPCR
$54.51
-$0.19-0.35%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 1.34B | 1.46B | 1.45B | 799.04M | 786.50M |
| Total Receivables | -- | -- | 100.00M | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 29.37M | 32.09M | 24.11M | 14.98M | 12.80M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 1.37B | 1.49B | 1.57B | 814.02M | 799.30M |
|
|
|||||
| Total Current Assets | 1.37B | 1.49B | 1.57B | 814.02M | 799.30M |
| Net Property, Plant & Equipment | 12.39M | 11.97M | 12.90M | 11.54M | 10.94M |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 41.00M | 5.56M | 717.00K | 6.60M | 6.20M |
| Total Assets | 1.43B | 1.51B | 1.58B | 832.16M | 816.44M |
|
|
|||||
| Total Accounts Payable | 11.13M | 7.82M | 13.86M | 17.80M | 8.99M |
| Total Accrued Expenses | 52.39M | 46.55M | 46.54M | 36.93M | 27.38M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 2.60M | 2.61M | 2.88M | 2.80M | 2.66M |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Current Liabilities | 66.11M | 56.98M | 63.29M | 57.53M | 39.03M |
|
|
|||||
| Total Current Liabilities | 66.11M | 56.98M | 63.29M | 57.53M | 39.03M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 3.63M | 3.18M | 3.61M | 4.29M | 5.01M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 1.27M | 863.00K | 647.00K | 325.00K | 317.00K |
| Total Liabilities | 71.01M | 61.03M | 67.54M | 62.14M | 44.36M |
|
|
|||||
| Common Stock & APIC | 2.01B | 2.00B | 1.99B | 1.27B | 1.21B |
| Retained Earnings | -652.43M | -546.27M | -470.30M | -503.30M | -437.59M |
| Treasury Stock & Other | -3.45M | -2.20M | 1.05M | 825.00K | 362.00K |
| Total Common Equity | 1.35B | 1.45B | 1.52B | 770.02M | 772.08M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 1.35B | 1.45B | 1.52B | 770.02M | 772.08M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 1.35B | 1.45B | 1.52B | 770.02M | 772.08M |
|
|
|||||